X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (34262) 34262
Book Review (4485) 4485
Publication (1734) 1734
Patent (407) 407
Newsletter (336) 336
Book Chapter (320) 320
Book / eBook (277) 277
Newspaper Article (209) 209
Magazine Article (152) 152
Conference Proceeding (117) 117
Paper (81) 81
Dissertation (30) 30
Government Document (30) 30
Web Resource (21) 21
Trade Publication Article (18) 18
Report (12) 12
Data Set (11) 11
Transcript (7) 7
Journal / eJournal (6) 6
Reference (3) 3
Presentation (1) 1
Streaming Video (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24904) 24904
humans (15503) 15503
male (9309) 9309
female (8012) 8012
animals (7892) 7892
essential oils (6833) 6833
essential oil (6514) 6514
middle aged (5384) 5384
adult (4835) 4835
pharmacology & pharmacy (4470) 4470
essential-hypertension (4330) 4330
aged (3596) 3596
analysis (3284) 3284
food science & technology (3239) 3239
antimicrobial activity (2735) 2735
oils, volatile - pharmacology (2727) 2727
biochemistry & molecular biology (2698) 2698
essential hypertension (2613) 2613
rats (2611) 2611
research (2433) 2433
peripheral vascular disease (2420) 2420
hypertension (2268) 2268
chemistry, medicinal (2197) 2197
health aspects (2104) 2104
hypertension - drug therapy (2060) 2060
mice (2054) 2054
chemical-composition (2053) 2053
oils, volatile - chemistry (1977) 1977
blood pressure - drug effects (1956) 1956
plant extracts - pharmacology (1914) 1914
microbiology (1894) 1894
microbial sensitivity tests (1817) 1817
in-vitro (1786) 1786
antioxidants (1768) 1768
antibacterial activity (1742) 1742
blood-pressure (1740) 1740
oils & fats (1699) 1699
hypertension - physiopathology (1666) 1666
dose-response relationship, drug (1603) 1603
plant sciences (1599) 1599
blood pressure (1596) 1596
risk factors (1569) 1569
chemistry, applied (1509) 1509
anti-bacterial agents - pharmacology (1490) 1490
antioxidant (1461) 1461
hematology (1450) 1450
physiological aspects (1448) 1448
essential thrombocythemia (1403) 1403
bacteria (1338) 1338
abridged index medicus (1332) 1332
care and treatment (1272) 1272
medicine (1251) 1251
antioxidant activity (1234) 1234
plant oils - pharmacology (1224) 1224
chemistry (1215) 1215
treatment outcome (1208) 1208
plants (1206) 1206
usage (1187) 1187
research article (1163) 1163
drugs (1158) 1158
constituents (1133) 1133
oxidative stress (1133) 1133
time factors (1132) 1132
biotechnology & applied microbiology (1130) 1130
plant extracts - chemistry (1129) 1129
inhibition (1120) 1120
gas chromatography-mass spectrometry (1117) 1117
cardiac & cardiovascular systems (1109) 1109
extracts (1107) 1107
growth (1101) 1101
disease (1093) 1093
nutrition & dietetics (1086) 1086
antihypertensive agents - therapeutic use (1085) 1085
proteins (1072) 1072
integrative & complementary medicine (1036) 1036
organic chemistry (1031) 1031
antifungal activity (1024) 1024
essential tremor (1008) 1008
aged, 80 and over (996) 996
oncology (987) 987
medicine, general & internal (983) 983
toxicity (982) 982
article (973) 973
leaves (973) 973
cell biology (972) 972
studies (969) 969
essential fatty acids (967) 967
adolescent (965) 965
clinical neurology (950) 950
cancer (939) 939
chemistry, multidisciplinary (932) 932
essences and essential oils (921) 921
antimicrobial agents (917) 917
life sciences (909) 909
polycythemia-vera (898) 898
food (895) 895
double-blind method (891) 891
neurosciences (890) 890
inflammation (885) 885
medicine, research & experimental (880) 880
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (79) 79
Online Resources - Online (15) 15
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
UofT at Mississauga - Stacks (10) 10
Robarts - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Engineering & Comp. Sci. - Stacks (6) 6
UTL at Downsview - May be requested (6) 6
UofT at Scarborough - Stacks (6) 6
Law (Bora Laskin) - Stacks (5) 5
Earth Sciences (Noranda) - Stacks (4) 4
OISE - Stacks (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
New College (Ivey) - Stacks (2) 2
OISE - Missing (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Art - Library use only (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
Media Commons - Audio Visual (1) 1
Robarts - Course Reserves (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35074) 35074
French (232) 232
German (231) 231
Russian (153) 153
Spanish (128) 128
Portuguese (124) 124
Japanese (122) 122
Chinese (119) 119
Korean (42) 42
Italian (23) 23
Polish (23) 23
Czech (12) 12
Persian (12) 12
Norwegian (10) 10
Dutch (9) 9
Hungarian (8) 8
Turkish (7) 7
Ukrainian (7) 7
Swedish (5) 5
Danish (4) 4
Croatian (2) 2
Slovenian (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Finnish (1) 1
Greek (1) 1
Hebrew (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, Global Health, ISBN 9781409426332, cm.
Hein and Moon take up a serious problem of contemporary global governance: what can be done when international trade rules prevent the realization of basic... 
Drug accessibility | Human Rights Law & Civil Liberties | Pharmaceutical Medicine | Comparative Politics | Global Governance | Medical & Healthcare Law | Drugs | Prices | International cooperation | Developing countries | Foreign trade regulation | Public health | Patents (International law) | Right to health
Book
USP dictionary of USAN and international drug names, ISSN 1076-4275, 1994
Journal
2002, World Bank discussion paper, ISBN 0821352121, Volume no. 437., xiii, 59 p. cm.
This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of... 
Drugs | Pharmaceutical policy | Pharmaceutical industry | Marketing | INFORMAL SECTOR | PHARMACY | PHARMACEUTICAL SERVICES | PHARMACEUTICAL MANUFACTURERS | PHYSICIANS | MEDICINAL DRUGS | DRUG UTILIZATION | DEVELOPED COUNTRIES | PHARMACISTS | HEALTH SECTOR | HUMAN DEVELOPMENT | PILL | VACCINES | NATIONAL DRUG POLICIES | NATIONAL DRUG POLICY | PRIVATE SECTOR | QUALITY CONTROL | GMP | LAWS | DISTRIBUTION OF PHARMACEUTICALS | PHARMACEUTICAL SUPPLY | NUTRITION | HEALTH CARE FINANCING | ADVERSE EFFECTS | PHARMACY CURRICULA | HOSPITALS | PHARMACEUTICAL COMPANIES | PHARMACEUTICAL POLICY | INCOME | DRUGS | INTERNATIONAL TRADE ACCOUNTING | NDP | HEALTH POLICY | TREATMENT GUIDELINES | THERAPEUTICS | PHARMACEUTICALS | PRODUCERS | MARKETING | PUBLIC EDUCATION | AVAILABILITY | PATENTS | SOCIAL SERVICES | SAFETY NETS | PHARMACEUTICALS PROCUREMENT | PUBLIC SECTOR | SAFETY | SANCTIONS | IRRATIONAL USE | ADVERTISING | INNOVATION | MEDICINES | PHARMACEUTICAL POLICIES | PHARMACEUTICAL SECTOR | DRUG LAW | DRUG INDUSTRY | PHARMACEUTICAL QUALITY ASSURANCE | DISCRIMINATION | GOVERNMENT REGULATIONS | GENERIC DRUGS | LOCAL PRODUCTION | PHARMACY SCHOOLS | PHARMACEUTICAL PATENTS | DRUG SELECTION | PHARMACEUTICAL RESEARCH | NURSING | DRUG PRICES | PHARMACEUTICAL QUALITY | AFFORDABILITY | TELECOMMUNICATIONS | COST SAVINGS | OIL | RATIONAL USE OF DRUGS | MEDICATION | INSURANCE | CERTIFICATION | DRUG CONTROL | PROCUREMENT | SOCIAL INSURANCE | MINISTRIES OF HEALTH | HUMAN BEHAVIOUR | PROPERTY RIGHTS | EXPENDITURES | IMPORTS | GENERIC SUBSTITUTION | BRAND NAME DRUGS | GOOD MANUFACTURING PRACTICES | HEALTH CARE SERVICES | LABORATORIES | PURCHASING | POLICY INSTRUMENTS | PHARMACEUTICAL INDUSTRY | SUSTAINABLE DEVELOPMENT | HEALTH CARE | ESSENTIAL DRUGS | ECONOMICS | HEALTH CARE COSTS | CONTRACTING OUT
Book
2010, Connecting international law with public law, ISBN 0521116562, xxi, 512
"This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis,... 
Drugs | Patents | Legislation, Drug | supply & distribution | International Cooperation | Patents as Topic | organization & administration | Drugs, Essential | Pharmaceutical policy | Health Services Accessibility | Patent laws and legislation | Human Rights | legislation & jurisprudence | Patents (International law)
Book
2010, Directions in development. Human development, ISBN 9780821383865, xxi, 215
This book discusses the wide range of challenges faced by policy makers in the pharmaceutical sector, presents the current know-how in terms of policy... 
economics | Developed Countries | Health Plan Implementation | Pharmaceutical policy | Drug Industry | Government Regulation | Health Policy | organization & administration | PHARMACY | INDUSTRIAL DEVELOPMENT | REGULATORY BARRIERS | SERVICE DELIVERY | PHYSICIANS | INTERNATIONAL AGREEMENTS | CITIZENSHIP | FIXED COSTS | HEALTH SECTOR | ABUSE | HUMAN DEVELOPMENT | PHARMACEUTICAL REGULATION | SUPPLY CHAIN | UNEMPLOYMENT RATES | ECONOMIC GROWTH | RETAIL PHARMACIES | GOOD GOVERNANCE | POLICY FRAMEWORK | PRIVATE PHARMACIES | PHARMACEUTICAL PROCUREMENT | PUBLIC POLICY | PRICE REGULATION | DIABETES | MEDICAL SUPPLIES | GMP | HEALTH SYSTEMS | BRIBERY | HEALTH WORKERS | PAYMENT TERMS | HEALTH SERVICES | MALARIA | PHARMACEUTICAL SUPPLY | HIGH BLOOD PRESSURE | TECHNICAL CAPACITY | MORTALITY | PATIENTS | FRAUD | BIOLOGICALS | CAPSULES | TUBERCULOSIS | HOSPITALS | NARCOTICS | SUPPLIER | DEVELOPING COUNTRIES | PHARMACEUTICAL POLICY | ACCOUNTABILITY | DECISION MAKING | HOME COUNTRIES | SALES | HEALTH POLICY | TURNOVER | TRANSPORTATION | DEMOCRACY | DOSAGE FORMS | MARKETING | HEALTH INSURANCE | MEDICAL SPECIALISTS | CHRONIC DISEASES | CLINICS | EDUCATION SYSTEMS | CENTRAL MEDICAL STORES | STOCKS | PURCHASING POWER | HEALTH OUTCOMES | REFORM EFFORT | COMPETITIVE BIDDING | MEDICINES | NATIONAL DRUG | CANCER | PHARMACEUTICAL POLICIES | NURSE | TABLETS | HEALTH CARE PROVIDERS | DRUG INDUSTRY | INVENTORY | DISCRIMINATION | DISTRIBUTION SYSTEMS | FAMILIES | CIVIL SOCIETY ORGANIZATIONS | DISABILITY | COMPLICATIONS | FAMILY MEMBERS | WHOLESALERS | CIF | DRUG PRICES | HEALTH SYSTEM | NATIONAL GOVERNMENT | CONSUMER GROUPS | BRAND | HUMAN IMMUNODEFICIENCY VIRUS | MEDICAL EDUCATION | MARKET ENTRY | HOSPITAL | OPERATING COSTS | CHEMISTS | SUPPLIERS | UNIVERSAL ACCESS | QUALITY ASSURANCE | LOCAL ECONOMY | ILLNESS | PROCUREMENT | RURAL AREAS | MEDICINE | GLOBAL DEVELOPMENT | REGULATORY AGENCIES | IMMUNIZATION | INDUSTRIAL PRODUCTION | CARDIOVASCULAR DISEASE | ENVIRONMENTAL PROTECTION | PROGRESS | URBAN POPULATION | GLOBAL POLICY | GOOD MANUFACTURING PRACTICES | INFORMATION SYSTEMS | LABORATORIES | DOMESTIC MANUFACTURERS | WORLD HEALTH ORGANIZATION | PACKAGING | RETAIL | CLINICAL TRIALS | POOLED PROCUREMENT | ACQUIRED IMMUNODEFICIENCY SYNDROME | POLITICAL DECISION | INTERMEDIARIES | HEALTH CARE | HEALTH CARE ACCESS | COMPETITIVENESS | PHARMACEUTICAL MANUFACTURERS | INVENTORY MANAGEMENT | CORRUPTION | PHARMACEUTICAL EXPENDITURE | CITIZENS | POLITICAL OPPOSITION | PRACTITIONERS | PHARMACISTS | LOW-INCOME COUNTRY | MEDICAL SCHOOL | NURSES | VACCINES | MEDICAL SERVICES | QUANTITATIVE DATA | WORKERS | NATIONAL LEGISLATION | QUALITY CONTROL | DEVELOPMENT GOALS | LAWS | PHARMACEUTICAL PRODUCTS | HEALTH CARE REFORM | MINISTRY OF HEALTH | DISSEMINATION | TRADE ISSUES | NUTRITION | POLITICAL SUPPORT | POLICY GOALS | PRESCRIPTIONS | USE OF RESOURCES | HEALTH CARE SYSTEM | PUBLIC HEALTH | RISK FACTORS | DEVELOPMENT POLICY | PUBLIC SUPPORT | PHARMACEUTICAL COMPANIES | PHARMACEUTICAL REFORM | LOCAL MANUFACTURERS | DRUGS | HEALTH MANAGEMENT | PHARMACEUTICALS | PHARMACEUTICAL MARKETS | PHARMACEUTICAL ¸ MANUFACTURERS | SERVICE QUALITY | HEALTH POLICIES | DEATH RATES | MANAGEMENT SYSTEMS | HIV | DRUG DONATIONS | LEGAL STATUS | MILLENNIUM DEVELOPMENT GOALS | PATIENT | HEALTH CENTERS | COMMODITIES | ESSENTIAL MEDICINES | MEDICAL NEEDS | PHARMACEUTICAL | IMPORTED DRUGS | PHARMACEUTICAL SECTOR | SUPPLY CHAINS | RESPECT | PERSONAL RELATIONSHIPS | POLICY DECISIONS | LIFE EXPECTANCY | GENERIC DRUGS | PHARMACOLOGISTS | LOW-INCOME COUNTRIES | WAREHOUSE | PHARMACIES | FUTURE GROWTH | PHARMACEUTICAL MARKETING | EMERGING MARKETS | RATIONAL USE OF DRUGS | HEALTH REFORM | IMMUNODEFICIENCY | SOCIAL SECURITY | DELIVERY SYSTEMS | FAVORITISM | DRUG CONTROL | INTERNATIONAL ORGANIZATIONS | SECURE SUPPLY | ILLNESSES | QUALITY OF CARE | CHILD MORTALITY | REGULATORY AUTHORITIES | MINISTRIES OF HEALTH | HEALTH FACILITIES | DONOR FINANCING | PHARMACEUTICAL PRICING | PURCHASING | UNEMPLOYMENT | GOVERNMENT AGENCIES | PHARMACEUTICAL INDUSTRY | PUBLIC HEALTH POLICY | POLICY MAKERS | WAREHOUSES | PHARMACEUTICAL PRICING POLICIES | BUDGETING | POLITICAL CHANGE | ESSENTIAL DRUGS | SERVICE PROVIDERS
Book
Circulation, ISSN 0009-7322, 03/2006, Volume 113, Issue 9, pp. 1213 - 1225
Journal Article
The EMBO Journal, ISSN 0261-4189, 12/2015, Volume 34, Issue 24, pp. 2985 - 2987
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.